ARS Pharmaceuticals (SPRY) Return on Sales [ROS] (2022 - 2026)
ARS Pharmaceuticals (SPRY) posted Return on Sales [ROS] of -182.62% for Q2 2026, up 120.33 percentage points from -302.95% a year earlier and up 82.56 percentage points from the prior quarter.
ARS Pharmaceuticals (SPRY) Return on Sales [ROS] (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at ARS Pharmaceuticals was -184.96%, down 132.13 percentage points year-over-year; for FY2025, it came in at -212.92%, down 209.47 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a four-year change of +140.40 percentage points (FY2021 to FY2025).
- In prior years, ARS Pharmaceuticals' Return on Sales [ROS] was -3.46% in FY2024 (+225063.21 pp), -225066.67% in FY2023 (-222367.88 pp), -2698.78% in FY2022 (-2345.46 pp) and -353.32% in FY2021.
- Quarterly Return on Sales [ROS] has run from a low of -619990.00% in Q1 2024 to a high of 54.51% in Q4 2024 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in seven of the last eight quarters, with an average year-over-year change of +136227.78 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2025, with a gain of 619523.71 percentage points; the weakest was Q1 2024, with a drop of 526425.00 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -265.18% (Q1 2026), -147.63% (Q4 2025) and -163.66% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | ARS Pharmaceuticals | 404.71 Mn | 260.91 Mn | 20.81 Mn | -182.62% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -182.62% |
| Mar 31, 2026 | -265.18% |
| Dec 31, 2025 | -147.63% |
| Sep 30, 2025 | -163.66% |
| Jun 30, 2025 | -302.95% |
| Mar 31, 2025 | -466.29% |
| Dec 31, 2024 | 54.51% |
| Sep 30, 2024 | -1,051.64% |
| Jun 30, 2024 | -3,068.00% |
| Mar 31, 2024 | -619,990.00% |
| Dec 31, 2023 | -225,066.67% |
| Sep 30, 2023 | -242,456.67% |
| Jun 30, 2023 | -206,030.00% |
| Mar 31, 2023 | -93,565.00% |
| Dec 31, 2022 | -2,698.78% |
| Sep 30, 2022 | -3,507.94% |
| Jun 30, 2022 | -1,367.24% |
| Mar 31, 2022 | -1,070.74% |
ARS Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();